Your Health, We Care

Home >News>Company News

How is Lucius Pharmaceutical in Laos? Established 5 Years, 200+ Generic Drug Varieties, 54 Anti-Canc

Release date: 2026-07-17 16:57:55     Recommended: 6

Lucius Pharmaceutical is one of the representative generic drug enterprises in Laos. The company was established in Vientiane, the capital of Laos, in 2020 and has been in operation for over five years. Its parent company can be traced back to Lucius Pharmaceutical Co., Ltd., founded in Hyderabad, India, in 2014.

Company Overview

Lucius Pharmaceutical is a legal pharmaceutical enterprise approved by the Lao government. The company is located in Thongmang Village, Xaythani District, Vientiane City, with a factory covering an area of approximately 210,000 square meters. It has built the Asia Pacific No.1 Smart Factory and introduced pharmaceutical equipment from China, the United States, Germany, and other countries. The company has obtained GMP (Good Manufacturing Practice) certification issued by the Lao Ministry of Health.

Product Line

As of June 2024, Lucius Pharmaceutical has more than 200 generic drug varieties. Its products cover multiple therapeutic areas, including anti-tumor drugs, cardiovascular drugs, hematology drugs, diabetes drugs, dermatology drugs, men's health drugs, and anti-aging drugs.

In the field of anti-cancer drugs, the company has obtained marketing approvals for 54 anti-cancer drugs. Representative products include Sotorasib, Osimertinib, Cabozantinib, Larotrectinib, Lorlatinib, Ivosidenib, Gilteritinib, and many other targeted therapeutic drugs. In addition, the company has launched global first-generic products such as Revumenib.

Production and Certification

Lucius Pharmaceutical has an annual generic drug production capacity exceeding 1.5 billion tablets. The company strictly organizes production in accordance with GMP standards and has established a full-process quality control system covering raw material procurement, production processes, and finished product inspection.

In October 2023, the World Health Organization (WHO) conducted a comprehensive assessment of Lucius Pharmaceutical's factory and confirmed that its facility fully complies with WHO standards. The company's production environment simultaneously meets GMP standards of Laos, the European Union, the United States, and China.

Market Presence

Lucius Pharmaceutical's business has expanded to multiple countries and regions, including Thailand, Indonesia, Cambodia, Vietnam, the Philippines, Singapore, Malaysia, Turkey, Japan, and China. The company's products are mainly sold to markets in Southeast Asia, the Middle East, Eastern Europe, and Africa.

For patients with medication needs, it is recommended to obtain drugs through formal channels under the professional guidance of a licensed physician or pharmacist.

Company News

Research News

Drug news